题 目：mechanistic dissection and immunotherapy of liver cancer

报告人：冯根生 教授

主持人：毕惠嫦 教授

时 间：2023年10月31日（周二）10:00-11:00

地 点：药学院四楼会议室

报告人简介：

Gen-Sheng Feng, Ph.D. is a Professor of Pathology and Molecular Biology at the University of California San Diego (UCSD). Dr. Feng’s research program is centered on dissecting the anti-oncogenic effects of pro-oncogenic proteins in the liver recently identified by his group and others. His most recent findings may lead to development of a preventive strategy for liver cancer in a huge population of patients with chronic liver diseases, and an effective combination immunotherapy for advanced liver cancer patients by coordinated activation of innate and adaptive immunity.

Dr. Feng received Ph.D. degree from Indiana University Bloomington, and did postdoctoral work with Dr. Bryan Williams at the Hospital for Sick Children, and with Tony Pawson at the Mt Sinai Hospital in Toronto, Canada. Dr. Feng has published 172 peer-reviewed research papers, reviews and book chapters in Science, Nature Medicine, Cancer Cell, PNAS, Immunity, Nature Immunology, Genes & Deve, MCB, JBC. Blood, Hepatology, J Hepatology and J. Immunol, etc. Dr. Feng has served on the editorial boards of Molecular and Cellular Biology (MCB), Journal of Biological Chemistry (JBC), Hepatology, and Journal of Hepatology. In 2016, Dr. Feng was elected as Fellow of American Association for the Advancement of Science (AAAS).